Market Tracker

09/02 2:52pm ET
26.29
Real-Time Quote
 +0.68 / +2.66%
Today’s Change
22.71
Today|||52-Week Range
41.28
-31.93%
Year-to-Date

Today’s Trading

Previous close25.61
Today’s open25.97
Day’s range25.87 - 26.50
Volume412,176
Average volume (3 months)520,518
Market cap$1.7B
Dividend yield--
Data as of 2:37pm ET, 09/02/2014

Growth & Valuation

Earnings growth (last year)-73.12%
Earnings growth (this year)-255.71%
Earnings growth (next 5 years)-1.00%
Revenue growth (last year)+23.14%
P/E ratioNM
Price/Sales3.26
Price/Book1.85

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...-0.18-0.34%
PDLIPDL BioPharma Inc-0.11-1.09%
CLVSClovis Oncology Inc+0.76+1.60%
IPXLImpax Laboratories I...+0.34+1.38%
Data as of 2:52pm ET, 09/02/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$687.9M
Annual profit (last year)$15.5M
Net profit margin2.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Clive A. Meanwell
President, CFO, Treasurer &
Director
Glenn P. Sblendorio
Corporate headquarters
Parsippany, New Jersey

Forecasts